A Multidisciplinary Approach to Coronavirus Disease (COVID-19)

Ertürk, Aliye Gediz; Şahin, Arzu; AY, Ebru BATI; Pelit, Emel; Bağdatlı, Emine; Kulu, İrem; Gül, Melek; Mesci, Seda; Eryılmaz, Serpil; Ilter, Sirin Oba; Yi̇ldi̇ri̇m, Tuba Talo

doi:10.3390/molecules26123526

Cited by 18 publications

(12 citation statements)

References 320 publications

(380 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…So, biologists, chemists, nutritionists, and traditional health practitioners are also not far from the integrative approach. 78 Multidisciplinary Digital Health Care…”

Section: Multidisciplinary Care For Comorbidity and Post-infection Complicationsmentioning

confidence: 99%

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up

Yayehrad¹,

Siraj²,

Yimenu³

et al. 2021

JMDH

View full text Add to dashboard Cite

It has been a year and a half since the world suffered the horrific COVID-19 pandemic which has still continued becoming a prominent headache for the whole world. Recently, we are facing the second and third wave of multivariate outbreaks with great intensity of transmission which renders huge disaster. Presently, new strains of the virus are emerging that are predicted to be resistant for the current vaccines and other management approaches. It needs collaborative and coordinated role at professional, facility, regional, and global levels to ameliorate the pandemic by monitoring the existing and emerging variants. This review addressed the multidisciplinary roles in patient screening and detection, emergency management, moderate and critical care, vaccination, complication prevention, comorbidity management, psychological therapy, and digital health care. The inevitable roles of academicians, researchers, private health sectors, policy makers, regulatory bodies, and partners are also discussed.

show abstract

“…So, biologists, chemists, nutritionists, and traditional health practitioners are also not far from the integrative approach. 78 Multidisciplinary Digital Health Care…”

Section: Multidisciplinary Care For Comorbidity and Post-infection Complicationsmentioning

confidence: 99%

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up

Yayehrad¹,

Siraj²,

Yimenu³

et al. 2021

JMDH

View full text Add to dashboard Cite

show abstract

“…The virus is an enveloped, single-stranded, positive-sense ribonucleic acid (RNA) viruses and belongs to the family Coronaviridae (subfamily Coronavirinae) [ 1 ]. It was first detected on 12 December 2019 in Wuhan City, Hubei Province, China [ 2 ]. Since then, it quickly spread to other countries around the world, becoming a threat to global health [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?

Catalano

Iacopetta

Ceramella

et al. 2022

Foods

View full text Add to dashboard Cite

The beginning of the end or the end of the beginning? After two years mastered by coronavirus disease 19 (COVID-19) pandemic, we are now witnessing a turnaround. The reduction of severe cases and deaths from COVID-19 led to increasing importance of a new disease called post-COVID syndrome. The term post-COVID is used to indicate permanency of symptoms in patients who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Immune, antiviral, antimicrobial therapies, as well as ozone therapy have been used to treat COVID-19 disease. Vaccines have then become available and administered worldwide to prevent the insurgence of the disease. However, the pandemic is not over yet at all given the emergence of new omicron variants. New therapeutic strategies are urgently needed. In this view, great interest was found in nutraceutical products, including vitamins (C, D, and E), minerals (zinc), melatonin, probiotics, flavonoids (quercetin), and curcumin. This review summarizes the role of nutraceuticals in the prevention and/or treatment of COVID-19 disease and post-COVID syndrome.

show abstract

“…In order to avoid nosocomial infections, it is needed a careful and timely assessment of the risk of having been infected in the asymptomatic patients or in those whose COVID-19 diagnosis has not been already made ( 5 – 7 ). This demands a multidisciplinary approach using a combination of anamnestic, clinical, microbiologic, and radiologic data to establish the earliest possible diagnosis ( 8 – 11 ).…”

Section: Introductionmentioning

confidence: 99%

Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric care

et al. 2022

View full text Add to dashboard Cite

Introduction/purposeSince a significant proportion of SARS-CoV-2 infections occur within healthcare facilities, a multidisciplinary approach is required for careful and timely assessment of the risk of infection in asymptomatic patients or those whose COVID-19 diagnosis has not yet been made. The aim of this study was to investigate whether an adaptative model based on microbiological testing can represent a valid risk management strategy.Material and methodsWe collected data from the risk management unit database of a 1,550-bed tertiary hospital (Fondazione Policlinico Gemelli IRCCS, Rome, Italy) concerning pediatric admissions to the Emergency Department (ED) from 1 March 2020 to 31 December 2021. The study period was subdivided in period A and period B according to the technique used for the microbiological screening, respectively reverse-transcription polymerase chain reaction (RT-PCR) and antigen-detection test.ResultsIn Period A, 426 children (mean age: 6 years) underwent microbiological screening at the ED. The total number of molecular tests performed was 463. 459/463 tested negative at the molecular test. In Period B, 887 children (mean age: 6 years) underwent microbiological screening in the ED. The total number of molecular tests performed was 1,154. 1,117/1,154 tested negative at the molecular test. Neither in Period A nor in Period B hospital-acquired SARS-CoV-2 infections were reported.Discussion and conclusionDespite high volumes, no cases of hospital-acquired SARS-CoV-2 infection have been reported. SARS-CoV-2 antigen-based tests can be used as a first-line option as they provide rapid results compared to RT-PCR, reducing the risk of infection in ED waiting rooms.

show abstract

A Multidisciplinary Approach to Coronavirus Disease (COVID-19)

Cited by 18 publications

References 320 publications

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?

Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric care

Contact Info

Product

Resources

About